2nd Annual NASH Summit 2018
When:
Monday, Apr 23, 2018 8:00a -
Wednesday, Apr 25, 2018 6:00p
Monday, Apr 23, 2018 8:00a -
Wednesday, Apr 25, 2018 6:00p
Where:
Revere Hotel Boston Common
200 Stuart Stree
Boston, MA 02116
Admission:
$699
Categories:
Lectures & Conferences
Event website:
http://go.evvnt.com/169819-0
As the industry's most comprehensive NASH forum, the NASH Summit returns with an unrivalled depth and breadth of cutting-edge NASH science from drug discovery through to late stage clinical development.
Across 3 parallel streams of learning, 48 expert speakers including Gilead, Allergan and Novartis will share advances in:
• Validating non-invasive biomarkers to confidently stratify patients and enhance clinical response
• Evaluating the scientific rationale behind combination therapy for more effective treatment
• Conclusively comparing in vitro and in vivo models to better recapitulate human NASH and confidently progress into the clinic
Join 150+ drug developers from 120+ organizations at this focused discussion and networking forum. Address this huge unmet clinical need and gain actionable insights to propel your candidate to therapeutic success.
Urls:
Brochure: https://go.evvnt.com/169819-1
Booking: https://go.evvnt.com/169819-2
Price
Conference Only: USD 2599
Workshop Only: USD 699
Speakers: Jason Campagna (Intercept Pharmaceuticals), Philip Just Larsen (Sanofi), Jamie Bates (Gilead Sciences), Dean Hurn (Genfit), Edgar Charles (Bristol-Myers Squibb)
